Description
Debridat suspension (DEBRIDAT) is a modern drug that has the property of regulating intestinal motility. It relieves spasms of smooth muscles and works exactly as needed in each specific case: for constipation, it has a relaxing effect, and for weak motor skills, on the contrary, it stimulates peristalsis.
Debridet suspension is used for functional disorders of the gastrointestinal tract, as well as in preparation for endoscopic examinations and operations.
Italian pharmacists produce Debridat in powder form for the preparation of a suspension, since the finished suspension has a very short shelf life. This dosage form of the drug has proven itself well because it is easy to use and allows you to accurately dose the drug in the right quantities for both children of any age (starting from infancy) and adults; Its orange flavor will appeal to kids who will happily take the medicine.
To obtain a suspension, add water to the powder until a volume of 250 ml is obtained (a special mark is indicated on the bottle) and shake thoroughly. After adding water, store the prepared suspension in the refrigerator for no more than 3 weeks.
Active substance: trimebutine 72 mg/15 ml (1 tablespoon).
Additional substances: sodium methyl benzoate, orange flavor, sucrose.
Debridat description and instructions for use of the drug.
Drug name:
Debridat
Release forms - powder for the preparation of oral suspension (bottles) 1.2 g - 250 ml
Pharmacological group - antispasmodic
pharmachologic effect
- increases intestinal tone and motility
- antispasmodic
- opioid receptor stimulating
Ingredients – trimebutine 1.2 g – 250 ml
Indications
- Pain in the abdomen and pelvis
- Pain localized in the upper abdomen
- Pain localized in other areas of the lower abdomen
- Peritoneal diseases
- Digestive diseases
- Diseases of the esophagus, stomach and duodenum
- Liver diseases
- Diseases of the gallbladder, biliary tract and pancreas
- Constipation
- Non-infectious gastroenteritis and colitis, unspecified
- Non-infectious enteritis and colitis
- Flatulence and related conditions
- Symptoms and signs related to the digestive system and abdominal cavity
- Functional diarrhea
- Other bowel diseases
- Other diseases of the digestive system
- Other and unspecified abdominal pain
- Other functional intestinal disorders
- Diarrhea and gastroenteritis of suspected infectious origin
Composition by components
- trimebutine
Pharmacodynamics
Debridate, acting on the enkephalinergic system of the intestine, is a regulator of its peristalsis. Having an affinity for excitation and inhibition receptors, it has a stimulating effect in hypokinetic conditions of intestinal smooth muscles and an antispasmodic effect in hyperkinetic conditions. The drug acts throughout the gastrointestinal tract (GIT), reduces the pressure of the esophageal sphincter, promotes gastric emptying and increased intestinal motility, and also promotes the response of the smooth muscles of the colon to food irritants. Debridet restores the normal physiological activity of the intestinal muscles in various gastrointestinal diseases associated with motility disorders.
Pharmacokinetics
Suction. After oral administration, the highest concentration of trimebutine in the blood plasma is achieved after 1-2 hours. Elimination. Trimebutine is rapidly excreted in the urine - approximately 70% during the first 24 hours.
Application
Therapy of polymorphic symptoms of gastroenterological diseases related to irritable bowel syndrome, a functional gastrointestinal disease, manifested, in particular, by pain and colic in the abdominal cavity, intestinal spasms, flatulence, diarrhea and/or constipation.
Dosage regimen
Tablets are prescribed for adults: 1-2 tablets (100-200 mg) 3 times a day. The oral suspension is prescribed to children under 6 months of age - 1/2 teaspoon 2-3 times a day; from 6 months to 1 year - 1 teaspoon 2 times a day; from 1 year to 5 years - 1 teaspoon 3 times a day; over 5 years - 2 teaspoons 3 times a day. For adults, the suspension is prescribed 1-2 tablespoons 3 times a day.
Side effects
Skin reactions are rare.
Contraindications
Currently, there are no contraindications to the use of the product. It is not recommended to use the product in the 1st trimester of pregnancy. It is not recommended to prescribe Debridat during lactation (breastfeeding), due to the lack of reliable clinical data confirming the safety of the product during this period. Experimental studies have not revealed any evidence of teratogenicity of the product.
special instructions
When prescribing the product to patients with diabetes, it should be taken into account that the powder for preparing an oral suspension contains sugar.
Attention! To use the drug "Debridat" you should obtain a detailed and complete consultation with your doctor. The instructions are provided solely for familiarization with “ Debridat ”.
Instructions
Before taking Debridat suspension, be sure to consult a specialist.
The approximate dosage of Debridet suspension depends on the patient’s age group:
- child up to six months - ½ tsp. 2-3 times a day;
- child from six months to one year - 1 tsp. 2 times a day;
- child from one year to five years - 1 tsp. 3 times a day;
- child over five years old - 2 tsp. 3 times a day;
- adult - 1 tbsp. 2-3 times a day.
Contraindications for taking Debridat suspension are:
- individual intolerance to Trimebutin;
- intestinal obstruction and diseases that cause such a symptom.
Debridat suspension should be taken with caution in patients with diabetes mellitus.
It is not recommended to take Debridat during the first trimester of pregnancy and during breastfeeding due to little clinical experience with trimebutine.
Side effects of Debridet suspension can manifest themselves in the form of minor allergic rashes on the skin, which go away on their own when the drug is discontinued.
The finished suspension requires special storage conditions - a temperature of +2 to +8 degrees. The shelf life for the finished suspension should not exceed 20 days. Before use, the suspension must be shaken each time.
Powder for preparing Debridat suspension can be stored at room temperature. Places where Debridat is stored in finished form, as well as in powder form, should be inaccessible to children.
Debridat instructions for use
INSTRUCTIONS for using the product
Debridat
Release form
Tablets, capsules , powders
Pharmacological properties
Debridate, acting on the enkephalinergic system of the intestine, is a regulator of its peristalsis. Having an affinity for excitation and suppression receptors, it has a stimulating effect in hypokinetic conditions of intestinal smooth muscles and an antispasmodic effect in hyperkinetic conditions. The drug acts throughout the gastrointestinal tract (GIT), reduces the pressure of the esophageal sphincter, promotes gastric emptying and increased intestinal motility, and also promotes the response of the smooth muscles of the colon to food irritants. Debridet restores the normal physiological activity of the intestinal muscles in various gastrointestinal diseases associated with motility disorders.
Indications
Debridet is used for the treatment of polymorphic symptoms of gastroenterological diseases related to irritable bowel syndrome (functional pathology of the gastrointestinal tract (GIT), which can manifest itself as flatulence, diarrhea and/or constipation, intestinal spasms, abdominal pain and colic), namely :
- pain in the abdomen and pelvis, localized in the upper, lower abdomen, and other areas;
- diseases of the peritoneum, digestive organs, esophagus, stomach and duodenum, liver, gall bladder, biliary tract and pancreas;
- constipation;
- non-infectious gastroenteritis and unspecified colitis;
- non-infectious enteritis and colitis;
- flatulence and related conditions;
- symptoms and signs of diseases related to the digestive system and abdominal cavity;
- functional diarrhea;
- other diseases of the intestines and digestive organs;
- other, including unspecified, abdominal pain;
- other functional intestinal disorders;
- diarrhea and gastroenteritis of presumably infectious etiology.
Contraindications
Hypersensitivity to the components of the drug, pregnancy (first trimester), lactation period.
Compound
Active ingredient: trimebutine:
Capsules – 150 mg/1 piece;
Suspension – 24 mg/5 ml (1 teaspoon) or 72 mg/15 ml (1 tablespoon).
Directions for use and doses
Before taking Debridat suspension, be sure to consult a specialist.
The approximate dosage of Debridet suspension depends on the patient’s age group:
-child up to six months - ½ tsp. 2-3 times a day;
-child from six months to one year - 1 tsp. 2 times a day;
-child from one to five years - 1 tsp. 3 times a day;
-child over five years old - 2 tsp. 3 times a day;
-adult - 1 tbsp. 2-3 times a day.
Side effects
When treated with Debridate, skin reactions are possible in some cases.
There have been no reliable reports of overdose.
Storage conditions
Store in a dry, dark place, out of reach of children, at a temperature not exceeding 25°C.
Best before date
3 years.
Indications for use
Debridet suspension is prescribed for various diseases that cause disturbances in intestinal motility:
- gastrointestinal diseases;
- non-infectious colitis, enteritis and gastroenteritis;
- problems with stool (flatulence, diarrhea and constipation) caused by stress, climate change, sedentary work, etc.;
- pain, colic in any part of the abdomen;
- diseases of the peritoneum;
- diseases of the liver, biliary tract and pancreas;
- preparing the patient for endoscopic and x-ray examinations of the gastrointestinal tract, preparation for operations.
Our company offers you only high-quality, original drug Debridat at an affordable price.
Please note that fluctuations in the euro exchange rate may result in price changes. Debridet suspension can be ordered with courier delivery in Moscow on the same day and by mail or transport company in the CIS.
Questions - Answers:
Where to buy Debridat suspension?
This effective drug is not included by the Ministry of Health in the register of medicines, so it is impossible to find it in regular pharmacies. We purchase Debridat from a pharmacy in Italy and deliver throughout Russia.
Debridat
Release forms - powder for the preparation of oral suspension (bottles) 1.2 g - 250 ml
Pharmacological group - antispasmodic
pharmachologic effect
- increases intestinal tone and motility
- antispasmodic
- opioid receptor stimulating
Ingredients – trimebutine 1.2 g – 250 ml
Indications
- Pain in the abdomen and pelvis
- Pain localized in the upper abdomen
- Pain localized in other areas of the lower abdomen
- Peritoneal diseases
- Digestive diseases
- Diseases of the esophagus, stomach and duodenum
- Liver diseases
- Diseases of the gallbladder, biliary tract and pancreas
- Constipation
- Non-infectious gastroenteritis and colitis, unspecified
- Non-infectious enteritis and colitis
- Flatulence and related conditions
- Symptoms and signs related to the digestive system and abdominal cavity
- Functional diarrhea
- Other bowel diseases
- Other diseases of the digestive system
- Other and unspecified abdominal pain
- Other functional intestinal disorders
- Diarrhea and gastroenteritis of suspected infectious origin
Composition by components
- trimebutine
Pharmacodynamics
Debridate, acting on the enkephalinergic system of the intestine, is a regulator of its peristalsis. Having an affinity for excitation and suppression receptors, it has a stimulating effect in hypokinetic conditions of intestinal smooth muscles and an antispasmodic effect in hyperkinetic conditions. The drug acts throughout the gastrointestinal tract (GIT), reduces the pressure of the esophageal sphincter, promotes gastric emptying and increased intestinal motility, and also promotes the response of the smooth muscles of the colon to food irritants. Debridet restores the normal physiological activity of the intestinal muscles in various gastrointestinal diseases associated with motility disorders.
Pharmacokinetics
Suction. After oral administration, the maximum concentration of trimebutine in the blood plasma is achieved after 1-2 hours. Elimination. Trimebutine is rapidly excreted in the urine - approximately 70% within the first 24 hours.
Application
Treatment of polymorphic symptoms of gastroenterological diseases related to irritable bowel syndrome, a functional gastrointestinal disease manifested, in particular, by pain and colic in the abdominal cavity, intestinal spasms, flatulence, diarrhea and/or constipation.
Dosage regimen
Tablets are prescribed for adults: 1-2 tablets (100-200 mg) 3 times a day. The oral suspension is prescribed to children under 6 months of age - 1/2 teaspoon 2-3 times a day; from 6 months to 1 year - 1 teaspoon 2 times a day; from 1 year to 5 years - 1 teaspoon 3 times a day; over 5 years - 2 teaspoons 3 times a day. For adults, the suspension is prescribed 1-2 tablespoons 3 times a day.
Side effects
Skin reactions are rare.
Contraindications
Currently, there are no contraindications to the use of the drug. It is not recommended to use the drug in the 1st trimester of pregnancy. It is not recommended to prescribe Debridat during lactation (breastfeeding), due to the lack of reliable clinical data confirming the safety of the drug during this period. Experimental studies have not revealed any evidence of teratogenicity of the drug.
special instructions
When prescribing the drug to patients with diabetes, it should be taken into account that the powder for preparing an oral suspension contains sugar.
